A novel intraperitoneal metastatic xenograft mouse model for survival outcome assessment of esophageal adenocarcinoma

Esophageal adenocarcinoma (EAC) has become the dominant type of esophageal cancer in United States. The 5-year survival rate of EAC is below 20% and most patients present with locally advanced or widespread metastatic disease, where current treatment is largely ineffective. Therefore, new therapeuti...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:PLoS One
Main Authors: Hassan, Md. Sazzad, Awasthi, Niranjan, Li, Jun, Schwarz, Margaret A., Schwarz, Roderich E., von Holzen, Urs
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2017
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5321464/
https://ncbi.nlm.nih.gov/pubmed/28225784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0171824
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki